Skip to content

Clinical trials

Phase 1 Breast Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Country / region: Australia Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20085
20111
20122
20131
20152
20161
20175
20185
20197
20207
20212
20224
20234
20249
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting20
Active, not recruiting11
Terminated11
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Novartis Pharmaceuticals5
Eli Lilly and Company4
BeOne Medicines3
GlaxoSmithKline3
Olema Pharmaceuticals, Inc.3
AbbVie2
AstraZeneca2
Genentech, Inc.2
MacroGenics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms67
Ovarian Neoplasms20
Carcinoma, Non-Small-Cell Lung19
Colorectal Neoplasms18
Endometrial Neoplasms15
Prostatic Neoplasms14
Stomach Neoplasms14
Triple Negative Breast Neoplasms14
Neoplasms13
Neoplasm Metastasis11

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.